RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth

The mammalian target of rapamycin (mTOR) is regulated by oncogenic growth factor signals and plays a pivotal role in controlling cellular metabolism, growth and survival. Everolimus (RAD001) is an allosteric mTOR inhibitor that has shown marked efficacy in certain cancers but is unable to completely...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyfeler, Beat, Chen, Yan, Li, Xiaoyan, Pinzon-Ortiz, Maria, Wang, Zuncai, Reddy, Anupama, Pradhan, Elina, Das, Rita, Lehár, Joseph, Schlegel, Robert, Finan, Peter M., Cao, Z. Alexander, Murphy, Leon O., Huang, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498278/
https://www.ncbi.nlm.nih.gov/pubmed/23155392
http://dx.doi.org/10.1371/journal.pone.0048548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498278/
https://www.ncbi.nlm.nih.gov/pubmed/23155392
http://dx.doi.org/10.1371/journal.pone.0048548

Ejemplares similares